OPEXA THERAPEUTICS INC's ticker is OPXA and the CUSIP is 68372T301. A total of 13 filers reported holding OPEXA THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $23,000 | -14.8% | 35,913 | 0.0% | 0.00% | – |
| Q1 2017 | $27,000 | -18.2% | 35,913 | 0.0% | 0.00% | – |
| Q4 2016 | $33,000 | -71.3% | 35,913 | 0.0% | 0.00% | – |
| Q3 2016 | $115,000 | -22.3% | 35,913 | 0.0% | 0.00% | – |
| Q2 2016 | $148,000 | +78.3% | 35,913 | 0.0% | 0.00% | – |
| Q1 2016 | $83,000 | -16.2% | 35,913 | 0.0% | 0.00% | – |
| Q4 2015 | $99,000 | -11.6% | 35,913 | 0.0% | 0.00% | – |
| Q3 2015 | $112,000 | – | 35,913 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| A.R.T. Advisors, LLC | 11,950 | $33,000 | 0.00% |
| Renaissance Technologies | 135,289 | $375,000 | 0.00% |
| THOMPSON DAVIS & CO., INC. | 400 | $1,000 | 0.00% |
| Virtu KCG Holdings LLC | 13,590 | $38,000 | 0.00% |
| VANGUARD GROUP INC | 152,161 | $423,000 | 0.00% |
| IFP Advisors, Inc | 6 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 35,913 | $99,000 | 0.00% |
| DEUTSCHE BANK AG\ | 1 | $0 | 0.00% |
| MORGAN STANLEY | 901 | $2,000 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 3,074 | $9,000 | 0.00% |